In this work, we focused on Sema6C, a poorly studied transmembrane semaphorin that was first discovered as an axonal chemorepellent [6], enriched in skeletal muscles and neuromuscular junctions [8], and implicated in ovarian follicles maturation [41], while its role in cancer context remains unclear. The gene discussed is SEMA6C; the disease is cancer.